This is characterized by the exposure of calreticulin (CRT), the release of ATP and high mobility group protein (HMGB1), followed by phagocytosis of tumor cells by dendritic cells (DCs) and activation of cytotoxic CD8+ T-lymphocytes [7]. The gene discussed is CALR; the disease is neoplasm.